This application requests continued support for a Program that provides structured, multidisciplinary research training of at least 2 years duration to 8 MD, PhD, or MD/PhD trainees per year. Trainees who are interested in defining the molecular and cellular basis of cardiovascular diseases, developing innovative approaches for imaging the cardiovascular system, and developing novel molecular and cellular therapies are all candidates for appointment to our Program. The Program builds on a strong tradition of cardiovascular research and clinical training at the University of Washington School of Medicine and exploits recent expansions in space and faculty dedicated to cardiovascular research. Training experiences are provided in four areas of opportunity within the broader field of cardiovascular disease research: (1) Signaling and Vascular Injury;(2) Molecular and Cellular Therapies;(3) Genetics and Genomics of Cardiovascular Risk;and (4) Biomechanics, Bioengineering, and Cardiovascular Imaging. Accordingly, the Program offers research training with faculty who hold primary appointments in 10 distinct academic Departments within the University of Washington and its affiliated institutions. The faculty is highly collaborative, as evidenced by joint publications, co-mentoring of trainees, and participation in Program Project and Center grants. Training supported by this Program includes a mentored research experience under the primary direction of one of our faculty, group activities such as didactic courses and seminars, activities organized and supported by this Program including a weekly seminar series on Cardiovascular Biology, a monthly Fellows Conference that is both didactic and focused on career development, semi-annual dinner presentations, and training in the """"""""survival skills"""""""" that are required for success as an independent investigator. Each of our trainees has a tailored training plan that is designed to broaden the trainee's scientific knowledge and provide essential skills. Individual training programs are developed by the trainee and mentor, are typically revised and expanded after review by the Program Director and Steering Committee, and are reviewed annually by the Committee. Involvement of a co-mentor from a different discipline than the primary mentor is a key feature of the Program. This Program is the major source of support for clinical fellows in Cardiology, Cardiovascular Pathology, and Vascular and Cardiothoracic Surgery who wish to acquire the skills that are necessary to carry out """"""""basic science"""""""" investigations as independent, principal investigators. The program is also a critical source of support for trainees with Ph.D. degrees who wish to pursue training in laboratories that have a significant focus on molecular and cellular biology and genetics of the mammalian cardiovascular system and that also envision clinical application of their discoveries.

Public Health Relevance

This Program supports full-time research training for individuals with doctoral degrees (MD, PhD, or both) who wish to develop careers that include significant involvement in cardiovascular research. Research training is provided in several areas including: identifying the causes of cardiovascular diseases;improving our ability to diagnose cardiovascular diseases;and enhancing our ability to treat and prevent cardiovascular diseases. The long-term goal of the Program is to train physicians and scientists who can lead these efforts.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-J (M4))
Program Officer
Carlson, Drew E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Konkle, B A; Johnsen, J M; Wheeler, M et al. (2018) Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project. Haemophilia 24 Suppl 6:87-94
Lee, Seung-Been; Wheeler, Marsha M; Patterson, Karynne et al. (2018) Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model. Genet Med :
Mikheev, Andrei M; Mikheeva, Svetlana A; Severs, Liza J et al. (2018) Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 12:1188-1202
Moccia, Amanda; Srivastava, Anshika; Skidmore, Jennifer M et al. (2018) Genetic analysis of CHARGE syndrome identifies overlapping molecular biology. Genet Med 20:1022-1029
Wacker, Bradley K; Dronadula, Nagadhara; Bi, Lianxiang et al. (2018) Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits. Arterioscler Thromb Vasc Biol 38:206-217
Wheeler, Marsha M; Lannert, Kerry W; Huston, Haley et al. (2018) Genomic characterization of the RH locus detects complex and novel structural variation in multi-ethnic cohorts. Genet Med :
Cusanovich, Darren A; Hill, Andrew J; Aghamirzaie, Delasa et al. (2018) A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility. Cell 174:1309-1324.e18
Wallingford, Mary C; Benson, Ciara; Chavkin, Nicholas W et al. (2018) Placental Vascular Calcification and Cardiovascular Health: It Is Time to Determine How Much of Maternal and Offspring Health Is Written in Stone. Front Physiol 9:1044
Walker, Matthew A; Tian, Rong (2018) Raising NAD in Heart Failure: Time to Translate? Circulation 137:2274-2277
Cao, Junyue; Cusanovich, Darren A; Ramani, Vijay et al. (2018) Joint profiling of chromatin accessibility and gene expression in thousands of single cells. Science 361:1380-1385

Showing the most recent 10 out of 154 publications